 phospholipase C-catalyzed hydrolysis content psoriatic involved uninvolved normal epidermis Evidence phospholipase C/protein kinase signal transduction system regulation epidermal cell growth differentiation Psoriatic epidermis hyperproliferation defective differentiation inflammation report activity phospholipase C-catalyzed hydrolysis content normal psoriatic uninvolved epidermis phospholipase C-catalyzed hydrolysis physiologic activator protein kinase hydrolysis soluble particulate fractions keratome biopsies normal psoriatic skin Total lipids normal psoriatic epidermis mixture enzyme assay potent activator protein kinase relative proportions uninvolved involved psoriatic epidermis separation acetate derivatives thin layer chromatography Soluble membrane-associated phospholipase C-catalyzed hydrolysis times times psoriatic involved uninvolved normal epidermis content times psoriatic involved versus uninvolved normal epidermis Analysis acetate derivatives psoriatic uninvolved involved epidermis major species significant differences phospholipase C-catalyzed hydrolysis content uninvolved normal epidermis purified normal involved psoriatic epidermis capable protein kinase normal epidermis vitro epidermal slices activation protein kinase addition protein kinase activity process down-regulation data consistent possibility elevation lesional content part reduction protein kinase activity psoriasis Horn Marks Fisher al Invest Dermatol